My goal is to develop substantial Australian capacity and international leadership in research on Health Impacts of Environment and Climate Change. Climate change poses diverse health risks, both direct (heatwaves, weather disasters, drought, urban air quality) and indirect (infectious disease patterns, food yields, economic loss, environmental refugee flows). My research group, with my own international connections and our strong cross-campus and external collaborative links, is ideally placed ....My goal is to develop substantial Australian capacity and international leadership in research on Health Impacts of Environment and Climate Change. Climate change poses diverse health risks, both direct (heatwaves, weather disasters, drought, urban air quality) and indirect (infectious disease patterns, food yields, economic loss, environmental refugee flows). My research group, with my own international connections and our strong cross-campus and external collaborative links, is ideally placed to do this research. Major outcomes will be: (i) enhanced understanding of the health risks from climate change and other human-induced environmental changes (including studies of their influences on patterns of infectious diseases); (ii) a broader evidence base for developing preventive-adaptive strategies to lessen health risks – and further development of my Centre’s high-level skills in translating research to social policy. My four specific aims are to: 1. Extend our research on the health impacts of climate change and other environmental changes. This will include strengthening further our international collaboration, developing new methods, and: (a) research on the health impacts of long-term drought in rural Australia; (b) elucidating the interplay of environmental, climatic, social and economic influences on infectious disease emergence and spread in the Australia-Asia region (to enhance ecological understanding, facilitate prevention-control strategies, and advance the biosecurity research agenda – including via ANU’s new Centre for Biosecurity). 2. Develop further our research on environmental and genetic influences on immune system function and autoimmune diseases, including studying the role of vitamin D. Answers to these research questions will be generalisable to the prevention and management of immune disorders. 3. Provide strong leadership in fostering international research activities, capacity and collaboration on the health impacts of global environmental-climatic changes (GEC). I have special opportunity and responsibility as co-chair of the International Council of Science project: ‘GEC and Human Health’. 4. Develop Australia’s population health research capacity with emphasis on training early-mid-career researchers. This fellowship research program would be greatly strengthened by retention of several high-performing and committed Team Investigators already working in the topic area. My central objective is to consolidate national research capacity and long-term momentum in the above areas, with high international engagement and profile. Under my directorship NCEPH has attained high visibility in: (i) climate change and health research; (ii) modeling infectious disease transmission and control; (iii) studying the environmental aetiology of immune disorders; and (iv) social-cultural epidemiological research into influences on health-reRead moreRead less
Estimating The Burden Of Group A Streptococcal Diseases In Victoria
Funder
National Health and Medical Research Council
Funding Amount
$386,760.00
Summary
Despite the considerable advances in the diagnosis and treatment of group A streptococcal (GAS) diseases made during the last century, the impressive spectrum of infections caused by this organism continues to have a significant impact in developed countries. This spectrum includes diseases that are mild but common (e.g. sore throat, skin sores), rare but very severe (e.g. bloodstream infections, flesh-eating bacteria) and those that are more common in developing countries and the Aboriginal pop ....Despite the considerable advances in the diagnosis and treatment of group A streptococcal (GAS) diseases made during the last century, the impressive spectrum of infections caused by this organism continues to have a significant impact in developed countries. This spectrum includes diseases that are mild but common (e.g. sore throat, skin sores), rare but very severe (e.g. bloodstream infections, flesh-eating bacteria) and those that are more common in developing countries and the Aboriginal population (e.g. rheumatic fever, kidney disease). Streptococcal sore throat remains one of the most common childhood infections, and severe group A streptococcal diseases are thought to be increasing in incidence in Australia. Yet, there are no accurate data on the incidence and costs of these or other GAS diseases in non-Aboriginal Australians, or in most other populations around the world. It is becoming more urgent to collect this data as numerous vaccine candidates are entering human trials, new approaches to the treatment of sore throat are emerging, and new strategies to treat and control the spread of severe disease are being developed. We propose a comprehensive strategy to measure the incidence, prevalence and costs of each group of GAS diseases. We will follow a group of families for 12 months to detect cases of GAS sore throat and skin sores and measure the impact on the family. We will survey children in schools to estimate the prevalence of skin sores. We will check hospital records to calculate the number of cases of rheumatic fever and kidney disease. And we will maintain surveillance for severe diseases by checking hospital and laboratory records. We will also check to see if family members of people with severe disease have the GAS bacterium in their throats. We will then compile these data into a comprehensive estimate of the burden of disease in Victoria, and estimate the cost-effectiveness of different treatment and prevention strategies.Read moreRead less
Investigating Low Sun Exposure And Other Possible Early Life Determinants Of Type 1 Diabtes Mellitus
Funder
National Health and Medical Research Council
Funding Amount
$342,795.00
Summary
Type 1 diabetes mellitus is becoming more common among Australian children. The project explores aspects of the modern child's environment that may increase the risk of type 1 diabetes. In particular it aims to assess whether very low sun exposure in early life is adverse. Low sun exposure may be adverse because sun exposure -derived vitamin D is vital for the developing child's immune system. We need to know what level of sunlight and vitamin D children need to prevent disease.